Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
5 ICREAs amongst the 1% most cited researchers of 2024 worldwide
Congratulations to all of them, and also to their host institutions for this well deserved recognition. · Josep Dalmau (FRCB-IDIBAPS)…
ERC Synergy grants 2024
Congratulations to Diego Blas, Mariona Graupera and Kostas Kostarelos on their recent success in one of the most prestigious of…